News

Vaxinano presents preclinical results of its anti-toxoplasma vaccine

Thursday, December 05th 2019

Didier Betbeder, CEO & CSO of Vaxinano, presents for the first time the preclinical results of the anti-toxoplasma vaccine, including non-human primates.

New Contract

Monday, July 01st 2019

Vaxinano Announces the Signing of a Third Research and Development Program with a Leader in the Vaccine Industry.

An E.coli vaccine as an alternative to the overuse of antibiotics in poultry

Thursday, June 06th 2019

Faced with the worldwide emergence of antibiotic resistance, Vaxinano obtains funding for research with Immunova Analises Biologicas and Lesaffre International to develop a vaccine against avian colibacillosis.

New contract

Wednesday, January 16th 2019

A new pharmaceutical industrial leader trusts Vaxinano for the development of veterinary vaccines.

2018 Innovation competition : Vaxinano received by the secretaries of state

Tuesday, December 11st 2018

This December 11 was held the award ceremony of the 2018 Innovation competition where Vaxinano was rewarded in the field of Health.

Vaxinano presents at the Maison de la Chimie

Wednesday, November 07th 2018

New contract

Monday, September 10th 2018

Vaxinano has signed a research contract with a third industrial partner to develop a new veterinary vaccine.

Contract renewal

Saturday, September 01st 2018

The first industrial partner of Vaxinano, a world leader in the animal pharmaceutical industry, has renewed their contract and underlined their confidence in the company.

New funding

Friday, May 04th 2018

Vaxinano has begun GMP-compliant pharmaceutical production in its vaccine platform